RG6209 / Roche - LARVOL DELTA

Pregonda: A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME) (clinicaltrials.gov) - P1 | N=151 | Active, not recruiting | Sponsor: Genentech, Inc. | Trial completion date: Apr 2027 ➔ Jan 2027 | Trial primary completion date: Feb 2027 ➔ Nov 2026

Trial completion date • Trial primary completion date • Diabetic Macular Edema • Ophthalmology

Pregonda: A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME) (clinicaltrials.gov) - P1 | N=151 | Active, not recruiting | Sponsor: Genentech, Inc. | Recruiting ➔ Active, not recruiting

Enrollment closed • Diabetic Macular Edema • Ophthalmology